Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026. [PDF]
Morimoto S +3 more
europepmc +1 more source
Modeling ALS in a dish: how organoids are transforming research. [PDF]
Galluzzi G +3 more
europepmc +1 more source
C9orf72 in myeloid cells prevents an inflammatory response to microbial glycogen. [PDF]
McCourt B +10 more
europepmc +1 more source
CHI3L1 (YKL-40) and Chit-1 expressing glia in the white matter of ALS, FTLD and AD: correlations to pathology and disease duration. [PDF]
Tran CM +4 more
europepmc +1 more source
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia. [PDF]
James RE +16 more
europepmc +1 more source
Exosome-like nanovesicles from acerola for CRISPR-Cas9 ribonucleoprotein delivery to the central nervous system. [PDF]
Nagamatsu Y +8 more
europepmc +1 more source
Gene Targeted Therapies for Neurodegenerative Disorders: Strategies and Implications in ALS and SMA. [PDF]
Yesbek Kaymaz A +3 more
europepmc +1 more source
γ-Radiation induces region-specific subcellular alterations of amyotrophic lateral sclerosis and frontotemporal dementia markers in swine brain. [PDF]
Iacono D, Murphy EK, Perl DP, Day RM.
europepmc +1 more source
Short tandem repeat expansions in patients with neurodegenerative dementia. [PDF]
Zhu Y +19 more
europepmc +1 more source

